Lars Bernfort1, Sam Nordfeldt, Jan Persson. 1. Center for Medical Technology Assessment, Department of Medical and Health Sciences, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Abstract
AIM: Attention deficit hyperactivity disorder (ADHD) and related disorders affect children's ability to function in school and other environments. Awareness has increased in recent years that the same problems often persist in adulthood. Based on previous studies, we aimed to outline and discuss a descriptive model for calculation of the societal costs associated with ADHD and related disorders. METHODS: Following a literature review including childhood and adult studies, long-term outcomes of ADHD and associated societal costs were outlined in a simple model. RESULTS: The literature concerning long-term consequences of ADHD and related disorders is scarce. There is some evidence regarding educational level, psychosocial problems, substance abuse, psychiatric problems and risky behaviour. The problems are likely to affect employment status, healthcare consumption, traffic and other accidents and criminality. A proposed model structure includes persisting problems in adulthood, possible undesirable outcomes (and their probabilities) and (lifetime) costs associated with these outcomes. CONCLUSIONS: Existing literature supports the conclusion that ADHD and related disorders are associated with a considerable societal burden. To estimate that burden with any accuracy, more detailed long-term data are needed.
AIM: Attention deficit hyperactivity disorder (ADHD) and related disorders affect children's ability to function in school and other environments. Awareness has increased in recent years that the same problems often persist in adulthood. Based on previous studies, we aimed to outline and discuss a descriptive model for calculation of the societal costs associated with ADHD and related disorders. METHODS: Following a literature review including childhood and adult studies, long-term outcomes of ADHD and associated societal costs were outlined in a simple model. RESULTS: The literature concerning long-term consequences of ADHD and related disorders is scarce. There is some evidence regarding educational level, psychosocial problems, substance abuse, psychiatric problems and risky behaviour. The problems are likely to affect employment status, healthcare consumption, traffic and other accidents and criminality. A proposed model structure includes persisting problems in adulthood, possible undesirable outcomes (and their probabilities) and (lifetime) costs associated with these outcomes. CONCLUSIONS: Existing literature supports the conclusion that ADHD and related disorders are associated with a considerable societal burden. To estimate that burden with any accuracy, more detailed long-term data are needed.
Authors: Lauren Yallop; Marni Brownell; Dan Chateau; John Walker; Michelle Warren; Dan Bailis; Michael Lebow Journal: Can J Psychiatry Date: 2015-10 Impact factor: 4.356
Authors: Stephanie D Smith; Lawrence A Vitulano; Liliya Katsovich; Shuaixing Li; Christina Moore; Fenghua Li; Heidi Grantz; Xixi Zheng; Virginia Eicher; Selin Aktan Guloksuz; Yi Zheng; Jinxia Dong; Denis G Sukhodolsky; James F Leckman Journal: J Atten Disord Date: 2016-05-13 Impact factor: 3.256
Authors: Xin Zhao; Timothy F Page; Amy R Altszuler; William E Pelham; Heidi Kipp; Elizabeth M Gnagy; Stefany Coxe; Nicole K Schatz; Brittany M Merrill; Fiona L Macphee; William E Pelham Journal: J Abnorm Child Psychol Date: 2019-08
Authors: Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson Journal: BMC Psychiatry Date: 2010-09-03 Impact factor: 3.630
Authors: Barbara Franke; Alejandro Arias Vasquez; Stefan Johansson; Martine Hoogman; Jasmin Romanos; Andrea Boreatti-Hümmer; Monika Heine; Christian P Jacob; Klaus-Peter Lesch; Miguel Casas; Marta Ribasés; Rosa Bosch; Cristina Sánchez-Mora; Núria Gómez-Barros; Noèlia Fernàndez-Castillo; Mònica Bayés; Anne Halmøy; Helene Halleland; Elisabeth T Landaas; Ole B Fasmer; Per M Knappskog; Angelien J G A M Heister; Lambertus A Kiemeney; J J Sandra Kooij; A Marije Boonstra; Cees C Kan; Philip Asherson; Stephen V Faraone; Jan K Buitelaar; Jan Haavik; Bru Cormand; Josep Antoni Ramos-Quiroga; Andreas Reif Journal: Neuropsychopharmacology Date: 2009-11-04 Impact factor: 7.853